AI assistant
Mankind Pharma Limited — Call Transcript 2024
Jul 25, 2024
61869_rns_2024-07-25_6add8c49-746a-4cf7-93c6-00699c9011ba.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [594 x 114] intentionally omitted <==
Date: July 25, 2024
BSE Limited P J Towers, Dalal Street, Mumbai – 400 001 Script Code: 543904
National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051
Symbol: MANKIND
Dear Sir/ Madam,
Subject: Intimation of conference call in relation to acquisition of 100% stake in Bharat Serums and Vaccines Limited
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company will hold a conference call for analysts and investors on Friday, July 26, 2024 at 04:00 p.m. (IST) in relation to acquisition of 100% stake in Bharat Serums and Vaccines Limited.
Details of the Conference Call are enclosed herewith.
The same are also being uploaded on website of the Company at www.mankindpharma.com.
You are requested to kindly take the same on records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Digitally signed PRADEEP by PRADEEP CHUGH CHUGH Date: 2024.07.25 22:11:08 +05'30'
Pradeep Chugh Company Secretary and Compliance Officer
Encl.: As above
==> picture [590 x 64] intentionally omitted <==
==> picture [148 x 95] intentionally omitted <==
Mankind Pharma Limited Investors / Analyst Call
You are cordially invited to the conference call, Scheduled on Friday, 26[th] July 2024, at 04:00 pm IST ,
To discuss acquisition of Bharat Serums and Vaccines Limited:
The details of the call are as below:
| Conference Call Details | Conference Call Details |
|---|---|
| Date | Friday, 26thJuly 2024 |
| Time | 04:00 pm - 05:00 pm, IST |
| Universal Dial-in | +91 22 6280 1102 +91 22 7115 8003 |
| International Toll-Free Numbers | USA : 18667462133 UK : 08081011573 Singapore : 8001012045 Hong Kong : 800964448 |
| Pre-register to avoid wait time | Click here to pre-register for the call and dial in directly without waiting for the operator. |
Management will be represented by:
-
Mr. Rajeev Juneja – Vice Chairman & Managing Director
-
Mr. Sheetal Arora – Chief Executive Officer & Whole Time Director
-
Mr. Arjun Juneja - Chief Operating Officer
-
Mr. Ashutosh Dhawan – Chief Financial Officer
-
Mr. Prakash Agarwal – President (Strategy)
-
Mr. Abhishek Agarwal – Head - Investor Relations & AVP - Strategy
For details, please contact:
| Mankind Pharma Limited Abhishek Agarwal E:[email protected], T: 011 – 46846700 |
Adfactors PR Snighter Albuquerque / Smit Shah E:[email protected]/ [email protected], M: +91 9870789596 |
|---|---|